Affectis Pharmaceuticals' Series B Round

Affectis Pharmaceuticals raised a round of funding on April 13, 2005.

Affectis Pharmaceuticals, fka neuronova, is a biopharmaceutical company developing drugs for the treatment of psychiatric and inflammatory disorders.…

Articles about Affectis Pharmaceuticals' Series B Round: